Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 18 results.
User Information
Export Records
  1. 1.   Immune profile diversity is achieved with synthetic TLR4 agonists combined with the RG1-VLP vaccine in mice
  2. Matthews, Rebecca L; Khan,Nazneen; Beckman,Bradley; Sharma, Simran; Dietz, Zackary; Picking, William D; Izmirlian, Grant; Sanders,Chelsea; Stocks,Stacy; Difilippantonio,Simone; Kirnbauer, Reinhard; Roden, Richard B; Pinto,Ligia; Shoemaker, Robert H; Ernst, Robert K; Marshall,Jason
  3. Vaccine. 2024, Dec 03; 126577.
  1. 2.   Adjuvants to the S1-subunit of the SARS-CoV-2 spike protein vaccine improve antibody and T cell responses and surrogate neutralization in mice
  2. Becker, William; Rebbani, Khadija; Duan, Zhijian; Valkov,Eugene; Bryant, Shawn; Ho, Mitchell; Berzofsky, Jay A; Olkhanud, Purevdorj B
  3. Scientific Reports. 2024, Nov 28; 14(1): 29609.
  1. 3.   Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model
  2. Sanders,Chelsea; Matthews,Rebecca; Esfahani, Sayyed Hamid Zarkesh; Khan,Nazneen; Patel,Nimit; Kalen,Joseph; Kirnbauer, Reinhard; Roden, Richard B; Difilippantonio,Simone; Pinto,Ligia; Shoemaker, Robert H; Marshall,Jason
  3. Vaccine. 2023, Jun 01;
  1. 4.   Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP
  2. Valencia, Sarah M.; Zacharia, Athina; Marin, Alexander; Matthews, Rebecca L.; Wu, Chia-Kuei; Myers, Breana; Sanders, Chelsea; Difilippantonio, Simone; Kirnbauer, Reinhard; Roden, Richard B.; Pinto, Ligia A.; Shoemaker, Robert H.; Andrianov, Alexander K.; Marshall, Jason D.
  3. Human Vaccines & Immunotherapeutics. 2021, Aug 3; 17(8): 2748-2761.
  1. 5.   Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists
  2. Zacharia,Athina; Harberts, Erin; Valencia, Sarah M; Myers,Breana; Sanders,Chelsea; Jain, Akshay; Larson, Nicholas R; Middaugh, C Russell; Picking, William D; Difilippantonio,Simone; Kirnbauer, Reinhard; Roden, Richard B; Pinto,Ligia; Shoemaker, Robert H; Ernst, Robert K; Marshall,Jason
  3. Vaccine. 2021, Jan 8; 39(2): 292-302.
  1. 6.   Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies
  2. Dobrovolskaia,Marina
  3. Molecules (Basel, Switzerland). 2019, Dec; 24(24):
  1. 7.   Effect of Calcium Carbonate Encapsulation on the Activity of Orally Administered CpG Oligonucleotides
  2. Kayraklioglu, Neslihan; Scheiermann, Julia; Alvord, W. Gregory; Klinman, Dennis
  3. MOLECULAR THERAPY-NUCLEIC ACIDS. 2017, Sep 15; 8: 243-249.
  1. 8.   Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery
  2. Gregg, Kelsey A.; Harberts, Erin; Gardner, Francesca M.; Pelletier, Mark R.; Cayatte, Corinne; Yu, Li; McCarthy, Michael P.; Marshall, Jason; Ernst, Robert K.
  3. MBIO. 2017, May-Jun; 8(3):
  1. 9.   Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals
  2. Ho, J.; Moir, S.; Wang, W.; Posada, J. G.; Gu, W. J.; Rehman, M. T.; Dewar, R.; Kovacs, C.; Sneller, M. C.; Chun, T. W.; Follmann, D. A.; Fauci, A. S.
  3. Aids. 2011, Jan; 25(3): 295-302.
  1. 10.   Anthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine
  2. Klinman, D. M.; Yamamoto, M.; Tross, D.; Tomaru, K.
  3. Expert Opinion on Biological Therapy. 2009, Dec; 9(12): 1477-86.
  1. 11.   Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization
  2. Mohamadzadeh, M.; Olson, S.; Kalina, W. V.; Ruthel, G.; Demmin, G. L.; Warfield, K. L.; Bavari, S.; Klaenhammer, T. R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, FEB 22; 102(8): 2880-2885.
  1. 12.   2-amino-O-4-benzylpteridines and O-4-benzylfolic acid: Potent inactivators of O-6-alkylguanine-DNA alkyltransferase and potential chemotherapy adjuvants
  2. Nelson, M. E.; Loktionova, N.; Pegg, A. E.; Moschel, R. C.
  3. Abstracts of Papers of the American Chemical Society. 2004, AUG 22; 228(Part 1): 110-MEDI, Abstract U927-110-MEDI, Abstract U927.
  1. 13.   Therapeutic idiotype vaccines in B lymphoproliferative diseases
  2. Coscia, M.; Kwak, L. W.
  3. Expert Opinion on Biological Therapy. 2004 4(6): 959-963.
  1. 14.   CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaques
  2. Verthelyi, D.; Wang, V. W.; Lifson, J. D.; Klinman, D. M.
  3. Aids. 2004 18(7): 1003-1008.
  1. 15.   Conditioned immune response to interferon-gamma in humans
  2. Longo, D. L.; Duffey, P. L.; Kopp, W. C.; Heyes, M. P.; Alvord, W. G.; Sharfman, W. H.; Schmidt, P. J.; Rubinow, D. R.; Rosenstein, D. L.
  3. Clinical Immunology. 1999 90(2): 173-181.
  1. 16.   The antineoplastic agent bryostatin-1 (Bryo-1) potently activates human monocytes to produce cytokines. Synergy with interleukin-2 (IL-2)
  2. Bosco, M. C.; Rottschafer, S.; Taylor, L. S.; Ortaldo, J. R.; Longo, D. L.; Espinoza-Delgado, I.
  3. Annual Meeting of the American Society of Clinical Oncology. 1997, 16 A1537.
  1. 17.   Detection of Nanoparticles' Ability to Stimulate Toll-Like Receptors Using HEK-Blue Reporter Cell Lines
  2. Cedrone,Edward; Dobrovolskaia,Marina
  3. Methods in Molecular Biology (Clifton, N.J.). 2023 2709: 241-251.
  1. 18.   Detection of Intracellular Complement Activation by Nanoparticles in Human T Lymphocytes
  2. Ilinskaya, Anna; Shah, Ankit; Van Dusen, Andrew; Dobrovolskaia,Marina
  3. Methods in Molecular Biology (Clifton, N.J.). 2024 2789: 109-120.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel